Mechanism-based therapies for pain

被引:9
作者
Block, BM [1 ]
Hurley, RW [1 ]
Raja, SN [1 ]
机构
[1] Johns Hopkins Univ, Div Pain Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA
关键词
D O I
10.1358/dnp.2004.17.3.829015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pain is a universal human experience. Usually pain is a normal homeostatic mechanism to force an organism to avoid or reduce injury. As such, the body has many pain messengers, receptors and neural pathways to sense that information. Sensing a stimulus that leads to, or has the potential to cause, tissue injury is termed "nociception." In clinical disease states, pain may be the result of tissue damage or aberrant signal processing. In either case, we may want to interrupt or reduce nociception to produce clinical analgesia. We will discuss the mechanisms of pain sensation, sites and actions of analgesic therapies presently used, and potential avenues for the development of novel pharmaceutical agents to interrupt the sensation and signaling of pain and thus provide pain relief or analgesia. Two other terms are used commonly in the pain literature, hyperalgesia and allodynia. Hyperalgesia is an increase in the magnitude of pain induced by a stimulus that is normally painful. Allodynia is when a usually nonpainful stimulus, like light touch, becomes painful. The review is divided into two parts: Nociceptors and Pain pathways to the brain. The first part discusses nociception at the peripheral nerve ending, while the second discusses the neurotransmission of pain signals to the spinal cord and up to the brain. (C) 2004 Prous Science. All rights reserved.
引用
收藏
页码:172 / 186
页数:15
相关论文
共 199 条
  • [1] EXCITATORY AMINO-ACID RECEPTORS AND NOCICEPTIVE NEUROTRANSMISSION IN RAT SPINAL-CORD
    AANONSEN, LM
    LEI, SZ
    WILCOX, GL
    [J]. PAIN, 1990, 41 (03) : 309 - 321
  • [2] mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs
    Ahn, SH
    Cho, YW
    Ahn, MW
    Jang, SH
    Sohn, YK
    Kim, HS
    [J]. SPINE, 2002, 27 (09) : 911 - 917
  • [3] The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
    Akopian, AN
    Souslova, V
    England, S
    Okuse, K
    Ogata, N
    Ure, J
    Smith, A
    Kerr, BJ
    McMahon, SB
    Boyce, S
    Hill, R
    Stanfa, LC
    Dickenson, AH
    Wood, JN
    [J]. NATURE NEUROSCIENCE, 1999, 2 (06) : 541 - 548
  • [4] Alden KJ, 2001, J PHARMACOL EXP THER, V297, P727
  • [5] Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla
    Antal, M
    Petko, M
    Polgar, E
    Heizmann, CW
    StormMathisen, J
    [J]. NEUROSCIENCE, 1996, 73 (02) : 509 - 518
  • [6] ANTONIJEVIC I, 1995, J NEUROSCI, V15, P165
  • [7] Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists
    Appendino, G
    Harrison, S
    De Petrocellis, L
    Daddario, N
    Bianchi, F
    Moriello, AS
    Trevisani, M
    Benvenuti, F
    Geppetti, P
    Di Marzo, V
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (08) : 1417 - 1424
  • [8] Direct activation of rat spinal dorsal horn neurons by prostaglandin E2
    Baba, H
    Kohno, T
    Moore, KA
    Woolf, CJ
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (05) : 1750 - 1756
  • [9] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial
    Backonja, M
    Beydoun, A
    Edwards, KR
    Schwartz, SL
    Fonseca, V
    Hes, M
    LaMoreaux, L
    Garofalo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21): : 1831 - 1836
  • [10] Bajic D, 1999, J COMP NEUROL, V405, P359